Citigroup Inc Ultragenyx Pharmaceutical Inc. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Citigroup Inc holds 43,493 shares of RARE stock, worth $1.74 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

43,493

Previous 20,475 112.42%

Holding current value

$1.74 Million

Previous $841,000 187.28%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$40.21 - $59.36 $925,553 - $1.37 Million	23,018 Added 112.42%	43,493 $2.42 Million
Q2 2024 Aug 12, 2024	SELL	$37.42 - $51.61 $5.1 Million - $7.04 Million	-136,374 Reduced 86.95%	20,475 $841,000
Q1 2024 May 10, 2024	BUY	$43.02 - $53.69 $1.99 Million - $2.49 Million	46,339 Added 41.93%	156,849 $7.32 Million
Q4 2023 Feb 09, 2024	BUY	$31.73 - $49.19 $632,378 - $980,356	19,930 Added 22.0%	110,510 $5.28 Million
Q3 2023 Nov 09, 2023	BUY	$34.92 - $46.66 $667,425 - $891,812	19,113 Added 26.74%	90,580 $3.23 Million
Q2 2023 Aug 10, 2023	SELL	$37.35 - $52.15 $3.16 Million - $4.41 Million	-84,568 Reduced 54.2%	71,467 $3.3 Million
Q1 2023 May 11, 2023	BUY	$36.99 - $48.71 $2.31 Million - $3.04 Million	62,510 Added 66.84%	156,035 $6.26 Million
Q4 2022 Feb 09, 2023	SELL	$33.72 - $46.33 $1.34 Million - $1.85 Million	-39,859 Reduced 29.88%	93,525 $4.33 Million
Q3 2022 Nov 10, 2022	BUY	$39.96 - $66.14 $1.95 Million - $3.24 Million	48,918 Added 57.91%	133,384 $5.52 Million
Q2 2022 Aug 10, 2022	BUY	$45.8 - $85.4 $2.8 Million - $5.22 Million	61,083 Added 261.23%	84,466 $5.04 Million
Q1 2022 May 12, 2022	SELL	$62.2 - $84.4 $2.21 Million - $3 Million	-35,565 Reduced 60.33%	23,383 $1.7 Million
Q4 2021 Feb 10, 2022	BUY	$73.71 - $87.86 $2.15 Million - $2.57 Million	29,199 Added 98.15%	58,948 $4.96 Million
Q3 2021 Nov 10, 2021	BUY	$77.92 - $102.4 $2.32 Million - $3.05 Million	29,749 New	29,749 $2.68 Million

Others Institutions Holding RARE

# of Institutions

325

Shares Held

85.5M

Call Options Held

520K

Put Options Held

406K

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $2.8B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account